Prognosis Factors in Patients with Copd and Atrial Fibrillation – Mini Review

Author:

Moales Elena-Andreea1,Zota Ioana Mădălina12,Tribus Laura Carina34,Cozma Corina Dima12,Mitu Florin1256

Affiliation:

1. 1 Faculty of Medicine , University of Medicine and Pharmacy ”Grigore T. Popa” , Iași , Romania

2. 2 Department of Medical Specialities (I) ,

3. 3 Department of Internal Medicine, Faculty of Dentistry , "Carol Davila" University of Medicine and Pharmacy , Bucharest , Romania

4. 4 Department of Internal Medicine , Ilfov County Emergency Hospital , Bucharest , Romania

5. 5 Academy of Medical Sciences, Ion C. Brătianu Boulevard No 1 , Bucharest , Romania

6. 6 Academy of Romanian Scientists, Professor Dr. Doc. Dimitrie Mangeron Boulevard No. 433 , , Iași , Romania

Abstract

Abstract Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF) are common pathologies in the elderly patient. The simultaneous occurrence of the two conditions influences the quality of life and increases the rate of exacerbations. About two-thirds of patients with atrial fibrillation have dyspnea. Severe dyspnea in the patient with COPD and AF can be difficult to manage, suggesting an exacerbation of the disease, the onset of atrial fibrillation or even a symptom of associated comorbidities, the most common of which being heart failure. The risk of developing AF in COPD increases with the severity of airflow obstruction. Factors such as smoking, aging, dyslipidemia, the presence of diabetes, hypertension or heart failure influence the prognosis of patients with COPD and AF. Furthermore, oxidative stress, hypoxia, systemic inflammation or immunological changes decrease the survival rate and may favor the recurrence of AF. In the evolution of concomitant COPD- FA cases, proinflammatory cytokines such as tumor necrosis factor α (TNF-α), monocyte chemotactic protein (MCP-1), interleukin-6 (IL-6), interleukin-8 (IL- 8) intervene. This paper aims at analyzing data related to the factors that would influence the prognosis of patients with COPD and AF.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3